Aurinia: Q3 Earnings Snapshot
EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $13.4 million in its third quarter.
On a per-share basis, the Edmonton, Alberta-based company said it had a loss of 9 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The biotechnology company posted revenue of $54.5 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $38.4 million.
Aurinia shares have risen 65% since the beginning of the year. The stock has decreased 11% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH